Breast cancer resistance protein (BCRP/ABCG2): New inhibitors and QSAR studies by a 3D linear solvation energy approach

Edwige Nicolle, Julien Boccard, David Guilet, Marie Geneviève Dijoux-Franca, Fabien Zelefac, Sira Macalou, Jeanne Grosselin, Julien Schmidt, Pierre Alain Carrupt, Attilio Di Pietro, Ahcène Boumendjel

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Abstract

A series of compounds derived from naturally occurring flavonoids and synthetic analogs have been evaluated on cell lines overexpressing the wild-type breast cancer resistance protein (BCRP/ABCG2) half-transporter. Human ABCG2-transfected cells were used for screening their inhibitory activity. Five new natural compounds obtained from Morus mesozygia Stapf and one synthetic chromone, comprising a flavonoidic scaffold, were also evaluated. Based on the results obtained with a total of 34 compounds, a 3D linear solvation energy QSAR was investigated by VolSurf descriptors of molecular-interaction fields (MIFs) related to hydrophobic-interaction forces, polarisability and hydrogen-bonding capacity. Accuracy of the constructed 3D-QSAR model was attested by a correlation coefficient r2 of 0.77. Shape parameters and hydrophobicity were revealed to be major physicochemical parameters responsible for the inhibition activity of flavonoid derivatives and synthetic analogs towards ABCG2, whereas hydrogen-bond donor capacity appeared highly unfavorable.

Original languageEnglish (US)
Pages (from-to)39-46
Number of pages8
JournalEuropean Journal of Pharmaceutical Sciences
Volume38
Issue number1
DOIs
StatePublished - Aug 12 2009

Keywords

  • 3D-QSAR
  • BCRP
  • Flavonoids
  • VolSurf descriptors

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Breast cancer resistance protein (BCRP/ABCG2): New inhibitors and QSAR studies by a 3D linear solvation energy approach'. Together they form a unique fingerprint.

Cite this